Published in Harm Reduct J on March 30, 2012
Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch Gen Psychiatry (1994) 11.85
Marijuana use motives and social anxiety among marijuana-using young adults. Addict Behav (2007) 2.16
Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study. Addiction (2009) 2.14
Legalization of marijuana: potential impact on youth. Pediatrics (2004) 2.02
Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Am J Psychiatry (2006) 1.78
The Structured Interview for Schizotypy (SIS): a preliminary report. Schizophr Bull (1989) 1.59
Peer influence and gender differences in problematic cannabis use among individuals with social anxiety. J Anxiety Disord (2006) 1.49
Social anxiety and problematic cannabis use: evaluating the moderating role of stress reactivity and perceived coping. Behav Res Ther (2005) 1.44
Quantification and comparison of marijuana smoking practices: blunts, joints, and pipes. Drug Alcohol Depend (2010) 1.15
Effects of marijuana on neurophysiological signals of working and episodic memory. Psychopharmacology (Berl) (2004) 1.09
Residual neuropsychologic effects of cannabis. Curr Psychiatry Rep (2001) 1.06
Challenges in quantifying marijuana use. Am J Addict (2009) 1.02
Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample. Psychol Med (2008) 0.98
The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia? Curr Opin Psychiatry (2008) 0.95
Substance use in adolescence and psychosis: clarifying the relationship. Annu Rev Clin Psychol (2010) 0.95
Preface. Neonatal Intensive Care Unit Network Neurobehavioral Scale. Pediatrics (2004) 0.78
Microduplications of 16p11.2 are associated with schizophrenia. Nat Genet (2009) 6.13
Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial. JAMA (2010) 3.94
Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. N Engl J Med (2009) 3.88
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci U S A (2010) 3.13
A comprehensive family-based replication study of schizophrenia genes. JAMA Psychiatry (2013) 2.93
Genomewide suggestive linkage of opioid dependence to chromosome 14q. Hum Mol Genet (2007) 1.54
Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. J Psychiatr Pract (2005) 1.30
A DTI study of white matter microstructure in individuals at high genetic risk for schizophrenia. Schizophr Res (2008) 1.26
An automated method to analyze language use in patients with schizophrenia and their first-degree relatives. J Neurolinguistics (2010) 1.07
Association between age at onset of psychosis and age at onset of cannabis use in non-affective psychosis. Schizophr Res (2012) 1.03
Long tandem repeats as a form of genomic copy number variation: structure and length polymorphism of a chromosome 5p repeat in control and schizophrenia populations. Psychiatr Genet (2009) 0.96
Heritability estimates for cognitive factors and brain white matter integrity as markers of schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2010) 0.91
The XVth World Congress of Psychiatric Genetics, October 7-11, 2007: Rapporteur summaries of oral presentations. Am J Med Genet B Neuropsychiatr Genet (2008) 0.88
Telomerase levels in schizophrenia: a preliminary study. Schizophr Res (2008) 0.86
A randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal. Am J Addict (2006) 0.86
Methylation of two Homo sapiens-specific X-Y homologous genes in Klinefelter's syndrome (XXY). Am J Med Genet B Neuropsychiatr Genet (2006) 0.84
Unique topology of language processing brain network: a systems-level biomarker of schizophrenia. Schizophr Res (2012) 0.83
Alterations in brain structures underlying language function in young adults at high familial risk for schizophrenia. Schizophr Res (2012) 0.82
CAA insertion polymorphism in the 3'UTR of Nogo gene on 2p14 is not associated with schizophrenia. Brain Res Mol Brain Res (2005) 0.82
Structural abnormalities in language circuits in genetic high-risk subjects and schizophrenia patients. Psychiatry Res (2012) 0.81
De novo truncating mutation in Kinesin 17 associated with schizophrenia. Biol Psychiatry (2010) 0.81
Disturbed functional connectivity of cortical activation during semantic discrimination in patients with schizophrenia and subjects at genetic high-risk. Brain Imaging Behav (2010) 0.80
Implementing a cognitive-behavioral pain self-management program in home health care, part 1: program adaptation. J Geriatr Phys Ther (2013) 0.80
Implementing a cognitive-behavioral pain self-management program in home health care, part 2: feasibility and acceptability cohort study. J Geriatr Phys Ther (2013) 0.79
Cerebral metabolism and mood in remitted opiate dependence. Drug Alcohol Depend (2007) 0.79
Dual diagnosis: alcoholism and co-morbid psychiatric disorders. Am J Addict (2003) 0.78
Can the care transitions measure predict rehospitalization risk or home health nursing use of home healthcare patients? J Healthc Qual (2013) 0.77
New developments in addiction treatment. J Clin Psychiatry (2006) 0.77
The 3rd Schizophrenia International Research Society Conference, 14-18 April 2012, Florence, Italy: summaries of oral sessions. Schizophr Res (2012) 0.76
The 2nd Schizophrenia International Research Society Conference, 10-14 April 2010, Florence, Italy: summaries of oral sessions. Schizophr Res (2010) 0.76
Summaries from the XIX World Congress of Psychiatric Genetics, Washington, DC, September 10-14, 2011. Am J Med Genet B Neuropsychiatr Genet (2012) 0.75
Selected summaries from the XVII World Congress of Psychiatric Genetics, San Diego, California, USA, 4-8 November 2009. Psychiatr Genet (2010) 0.75
25 years of editing Schizophrenia research: a unique and gratifying journey. Schizophr Res (2012) 0.75
Physical examination of substance abusers. Postgrad Med (1995) 0.75
Schizophrenia treatment: entering a new decade. Curr Opin Psychiatry (2010) 0.75
Sports chronobiology consultation: from the lab to the arena. Clin Sports Med (2005) 0.75